Effectiveness of the Strengthening Families Programme in the UK at preventing substance misuse in 10-14 year-olds: a pragmatic randomised controlled trial.
community child health
public health
substance misuse
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
21 02 2022
21 02 2022
Historique:
entrez:
22
2
2022
pubmed:
23
2
2022
medline:
23
3
2022
Statut:
epublish
Résumé
The Strengthening Families Programme 10-14 (SFP10-14) is a USA-developed universal group-based intervention aiming to prevent substance misuse by strengthening protective factors within the family. This study evaluated a proportionate universal implementation of the adapted UK version (SFP10-14UK) which brought together families identified as likely/not likely to experience/present challenges within a group setting. Pragmatic cluster-randomised controlled effectiveness trial, with families as the unit of randomisation and embedded process and economic evaluations. The study took place in seven counties of Wales, UK. 715 families (919 parents/carers, 931 young people) were randomised. Families randomised to the intervention arm received the SFP10-14 comprising seven weekly sessions. Families in intervention and control arms received existing services as normal. Primary outcomes were the number of occasions young people reported drinking alcohol in the last 30 days; and drunkenness during the same period, dichotomised as 'never' and '1-2 times or more'. Secondary outcomes examined alcohol/tobacco/substance behaviours including: cannabis use; weekly smoking (validated by salivary cotinine measures); age of alcohol initiation; frequency of drinking >5 drinks in a row; frequency of different types of alcoholic drinks; alcohol-related problems. Retention: primary analysis included 746 young people (80.1%) (alcohol consumption) and 732 young people (78.6%) (drunkenness). There was no evidence of statistically significant between-group differences 2 years after randomisation for primary outcomes (young people's alcohol consumption in the last 30 days adjusted OR=1.11, 95% CI 0.72 to 1.71, p=0.646; drunkenness in the last 30 days adjusted OR=1.46, 95% CI 0.83 to 2.55, p=0.185). There were no statistically significant between-group differences for other substance use outcomes, or those relating to well-being/stress, and emotional/behavioural problems. Previous evidence of effectiveness was not replicated. Findings highlight the importance of evaluating interventions when they are adapted for new settings. ISRCTN63550893.Cite Now.
Identifiants
pubmed: 35190414
pii: bmjopen-2021-049647
doi: 10.1136/bmjopen-2021-049647
pmc: PMC8862464
doi:
Types de publication
Journal Article
Pragmatic Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e049647Subventions
Organisme : Medical Research Council
ID : MR/L002787/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023233/1
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : SPHSU14
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802128
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12017/14
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00022/1
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: All authors declare financial support from the National Prevention Research Initiative (managed by the Medical Research Council), Welsh Government and Cardiff Strengthening Families Team. DF’s institution has previously received financial support for the development of the SFP10-14UK programme materials from the alcohol industry.
Références
BMC Public Health. 2006 Nov 23;6:287
pubmed: 17123446
BMC Public Health. 2012 Aug 31;12:723
pubmed: 22938046
Eur J Public Health. 2014 Jun;24(3):354-5
pubmed: 24723690
J Consult Clin Psychol. 2016 Oct;84(10):913-21
pubmed: 27548031
Eur J Public Health. 2015 Oct;25(5):900-1
pubmed: 26275986
Arch Pediatr Adolesc Med. 2006 Sep;160(9):876-82
pubmed: 16953009
J Adolesc Health. 2012 Apr;50(4):414-7
pubmed: 22443848
Psychol Med. 2018 Mar;48(4):694-696
pubmed: 28889806
Eur J Public Health. 2014 Aug;24(4):578-84
pubmed: 24078373
BMC Med Inform Decis Mak. 2009 Jan 16;9:3
pubmed: 19149883
Child Adolesc Ment Health. 2016 Feb;21(1):21-29
pubmed: 32680365
BMC Public Health. 2014 Jan 17;14:49
pubmed: 24438460
BMJ. 2009 Jul 07;339:b2534
pubmed: 19584408
Annu Rev Psychol. 2011;62:189-214
pubmed: 19575606
Lancet. 2018 Dec 8;392(10163):2452-2464
pubmed: 30473366
J Consult Clin Psychol. 2014 Dec;82(6):949-63
pubmed: 24821095
Arch Dis Child. 2007 Jan;92(1):34-8
pubmed: 16920756
J Adolesc. 2016 Jun;49:181-90
pubmed: 27088658
J Consult Clin Psychol. 2004 Jun;72(3):535-42
pubmed: 15279537
SSM Popul Health. 2017 Dec;3:255-265
pubmed: 29302612
Eur J Public Health. 2016 Dec;26(6):953-959
pubmed: 27374805
Health Educ Res. 2007 Aug;22(4):547-60
pubmed: 17041022
Int J Equity Health. 2015 Sep 15;14:81
pubmed: 26369339
Eur J Public Health. 2017 Jun 1;27(3):494-500
pubmed: 28339547